Quansah, Emmanuel
Peelaerts, Wouter
Langston, J. William
Simon, David K.
Colca, Jerry
Brundin, Patrik
Funding for this research was provided by:
FWO Flanders
Fulbright Belgium
Cure Parkinson’s Trust
Van Andel Research Institute
Integrated DNA Technologies
Article History
Received: 21 March 2018
Accepted: 17 May 2018
First Online: 24 May 2018
Competing interests
: PB has received commercial support as a consultant from Renovo Neural, Inc., Cellular Dynamics International, Axial Biotherapeutics, Roche, Teva Inc., Lundbeck A/S, NeuroDerm, AbbVie, ClearView Healthcare, FCB Health, IOS Press Partners and Capital Technologies, Inc. PB has ownership interests in Acousort AB. EQ and PB are conducting sponsored research on behalf of Roche and Lundbeck A/S. JC is co-founder and part-owner of MSDC.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.